Form 4: enVVeno Medical Corp Executive Granted Stock Options

Marc H. Glickman, SVP & Chief Medical Officer of enVVeno Medical Corp, was granted 75,000 stock options on December 18, 2024.

Summary

• Marc H. Glickman, the SVP & Chief Medical Officer of enVVeno Medical Corp, received 75,000 stock options on December 18, 2024.
• These options were granted under the company's Amended and Restated 2016 Omnibus Incentive Plan.
• The options have an exercise price of $2.57 and will vest in equal quarterly installments over three years, through 2027.
• The options expire on December 18, 2034.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed positively as it aligns management's interests with shareholders. There is no indication of any negative sentiment.

Positives

• The granting of stock options aligns the executive's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the executive.

Risks

• The value of the options is dependent on the future performance of the company's stock price.
• There is a risk that the options may not be valuable if the stock price does not increase above the exercise price.

Future Outlook

The stock options will vest over the next three years, incentivizing the executive to contribute to the company's long-term success.

Industry Context

Stock option grants are a common practice in the biotechnology industry to attract and retain key talent and align their interests with shareholders.

Comparison to Industry Standards

• Stock option grants are a standard form of compensation for executives in the biotech industry, often with vesting schedules to encourage long-term performance.
• The vesting schedule of quarterly installments over three years is typical for such grants.
• The exercise price of $2.57 is specific to enVVeno Medical Corp's stock price at the time of the grant.

Stakeholder Impact

• Shareholders may view the stock option grant positively as it incentivizes management to increase the company's value.
• Employees may see this as a positive sign of the company's commitment to its leadership.

Key Dates

Keywords

stock options, executive compensation, insider trading, equity, vesting, enVVeno Medical Corp, NVNO